A Path Forward for Families with Hereditary Cancer

Lynch syndrome is the most common cause of
hereditary cancers but difficult to diagnose.
Lynsight offers a new way to test for Lynch
syndrome, so healthcare providers can focus on
the path instead of the problem.

Lynch syndrome is the most common cause of hereditary cancers but difficult to diagnose. Lynsight offers a new way to test for Lynch syndrome, so healthcare providers can focus on the path instead of the problem.

For Patients & Families

For Providers

For Payers

1 in

279

People have Lynch syndrome

But only 35% of Lynch syndrome cases are confirmed through DNA sequencing, leaving patients, families, and providers in a state of uncertainty.

DiagMMR is Lynsight’s simple and accurate test that reliably detects mismatch repair (MMR) deficiency, supporting early Lynch syndrome diagnosis.

Lynch syndrome research

Founded by the leaders
in Lynch syndrome research

Lynsight has been on the forefront of Lynch syndrome research for over 25 years, driven by the mission to find a better way to help people prevent cancer. What started in the labs of the University of Helsinki in the 1990s will not stop until every potential Lynch syndrome case is tested

LS CancerDiag Rebrands to Lynsight

A Path Forward for Families with Hereditary Cancer

Lynch syndrome is the most common cause of
hereditary cancers but difficult to diagnose.
Lynsight offers a new way to test for Lynch
syndrome, so healthcare providers can focus on
the path instead of the problem.

1

in

279

People have Lynch syndrome

Lynch syndrome research

Founded by the leaders
in Lynch syndrome research

Sign Up For the Latest From Lynsight

A Path Forward for Families with Hereditary Cancer

Lynch syndrome is the most common cause of
hereditary cancers but difficult to diagnose.
Lynsight offers a new way to test for Lynch
syndrome, so healthcare providers can focus on
the path instead of the problem.

1

in

279

People have Lynch syndrome

Lynch syndrome research

Founded by the leaders
in Lynch syndrome research

LS CancerDiag Rebrands to Lynsight

A Path Forward for Families with Hereditary Cancer

Lynch syndrome is the most common cause ofhereditary cancers but difficult to diagnose.Lynsight offers a new way to test for Lynchsyndrome, so healthcare providers can focus onthe path instead of the problem.

1

in

279

People have Lynch syndrome

Lynch syndrome research

Founded by the leaders in Lynch syndrome research

Sign Up For the Latest From Lynsight

A Path Forward for Families with Hereditary Cancer

Lynch syndrome is the most common cause ofhereditary cancers but difficult to diagnose.Lynsight offers a new way to test for Lynchsyndrome, so healthcare providers can focus onthe path instead of the problem.

1

in

279

People have Lynch syndrome

Lynch syndrome research

Founded by the leaders in Lynch syndrome research

Lynch syndrome is the most common cause of
hereditary cancers but difficult to diagnose.
Lynsight offers a new way to test for Lynch
syndrome, so healthcare providers can focus on
the path instead of the problem.

Founded by the leaders
in Lynch syndrome research

Lynch syndrome is the most common cause of
hereditary cancers but difficult to diagnose.
Lynsight offers a new way to test for Lynch
syndrome, so healthcare providers can focus on
the path instead of the problem.

Founded by the leaders
in Lynch syndrome research